Salarius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -1 | ||
EBITDA | -1,487 | -1,005 | -1,466 | -1,770 |
EBIT | -1,488 | -1,006 | -1,467 | -1,771 |
Net Income | -1,463 | -972 | -1,424 | -1,715 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -742 | -1,356 | -1,072 | -1,353 |
Cash | 2,434 | 3,284 | 3,272 | 4,373 |
Basic Shares | 962 | 1,281 | 600 | 524 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,840 |
Gross Profit | -10 | -6 | 1,821 | |
EBITDA | -2 | -31,601 | -12,793 | |
EBIT | -12 | -31,607 | -12,812 | |
Net Income | -5,575 | -12,542 | -31,374 | -12,768 |
Net Change In Cash | 0 | 0 | 0 | 1,840 |
Free Cash Flow | -4,525 | -12,846 | -19,095 | -10,200 |
Cash | 2,434 | 5,899 | 12,106 | 29,214 |
Basic Shares | 962 | 3,264 | 2,124 | 206 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.01 |
2024-09-30 | -$0.76 |
2024-06-30 | -$2.37 |
2024-03-31 | -$0.41 |
